Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Neuroimmunology
Questions discussed in this category
What treatment strategies would you utilize in a patient with newly diagnosed HLA-B27+ axial spondyloarthritis (with active and chronic sacroiliitis on MRI) and recent diagnosis of MS that is well-controlled MS ocrelizumab given the need to avoid TNF inhibitors?
Patient did not have improvement with NSAIDs. Would you consider adding IL-17 blockade? Do you consider reduced dosing schedules in the setting of dua...
1 Answer available
26635
Related Topics
Neurology
Neuro-infectious disease
Rheumatology
Spondyloarthritis
Multiple sclerosis